Search hospitals > Ontario > LONDON
London Health Sciences Centre - University Hospital
Claim this profileLONDON, Ontario N6A 5A5
Global Leader in Inflammatory Bowel Disease
Global Leader in Ulcerative Colitis
Conducts research for Ulcer
Conducts research for Crohn's Disease
Conducts research for Osteoarthritis
184 reported clinical trials
10 medical researchers
Summary
London Health Sciences Centre - University Hospital is a medical facility located in LONDON, Ontario. This center is recognized for care of Inflammatory Bowel Disease, Ulcerative Colitis, Ulcer, Crohn's Disease, Osteoarthritis and other specialties. London Health Sciences Centre - University Hospital is involved with conducting 184 clinical trials across 192 conditions. There are 10 research doctors associated with this hospital, such as Michael Chu, MD, James Howard, MD, Vipul Jairath, and Habib R Khan, MD.Top PIs
Michael Chu, MDLondon Health Sciences Centre2 years of reported clinical research
Studies Mitral Valve Regurgitation
Studies Coronary Artery Disease
15 reported clinical trials
23 drugs studied
James Howard, MDLondon Health Sciences Centre6 years of reported clinical research
Studies Osteoarthritis
Studies Hip Osteoarthritis
7 reported clinical trials
16 drugs studied
Vipul JairathLondon Health Sciences Centre1 year of reported clinical research
Studies Inflammatory Bowel Disease
Studies Ulcer
11 reported clinical trials
10 drugs studied
Habib R Khan, MDLondon Health Sciences Centre1 year of reported clinical research
Studies Cardiomyopathy
Studies Arrhythmogenic Cardiomyopathy
3 reported clinical trials
5 drugs studied
Clinical Trials running at London Health Sciences Centre - University Hospital
Ulcerative Colitis
Inflammatory Bowel Disease
Ulcer
Heart Failure
Post-Traumatic Stress Disorder
COVID-19
Coronavirus
Atrial Fibrillation
Cardiomyopathy
Aortic Valve Stenosis
Mirikizumab
for Ulcerative Colitis
A study to investigate bowel urgency in adults with moderately to severely active ulcerative colitis (UC) treated with mirikizumab. The study will have 4 periods and will last for 36 weeks.
Recruiting2 awards Phase 3
Combination Therapy
for Ulcerative Colitis
The purpose of this study is to evaluate the efficacy and safety of JNJ-78934804 as compared to guselkumab and golimumab in participants with moderately to severely active ulcerative colitis who have had an inadequate initial response, loss of response, or intolerance to one or more approved advanced therapy.
Recruiting0 awards Phase 24 criteria
TAK-279
for Ulcerative Colitis
The main aim of this study is to learn if TAK-279 reduces bowel inflammation and symptoms compared to placebo. Another aim is to compare any medical problems that participants have when they take TAK-279 or placebo and how well the participants tolerate any problems. The participants will take capsules of either TAK-279 or placebo for up to 3 months (12 weeks). Then all the participants will receive TAK-279 for the rest of the treatment part of the study (1 year or 52 weeks). During the study, participants will visit their study clinic several times.
Recruiting0 awards Phase 21 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at London Health Sciences Centre - University Hospital?
London Health Sciences Centre - University Hospital is a medical facility located in LONDON, Ontario. This center is recognized for care of Inflammatory Bowel Disease, Ulcerative Colitis, Ulcer, Crohn's Disease, Osteoarthritis and other specialties. London Health Sciences Centre - University Hospital is involved with conducting 184 clinical trials across 192 conditions. There are 10 research doctors associated with this hospital, such as Michael Chu, MD, James Howard, MD, Vipul Jairath, and Habib R Khan, MD.